Cargando…
Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
Functional delivery of mRNA has high clinical potential. Previous studies established that mRNAs can be delivered to cells in vitro and in vivo via RNA-loaded lipid nanoparticles (LNPs). Here we describe an alternative approach using exosomes, the only biologically normal nanovesicle. In contrast to...
Autores principales: | Tsai, Shang Jui, Atai, Nadia A., Cacciottolo, Mafalda, Nice, Justin, Salehi, Arjang, Guo, Chenxu, Sedgwick, Alanna, Kanagavelu, Saravana, Gould, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483990/ https://www.ncbi.nlm.nih.gov/pubmed/34600888 http://dx.doi.org/10.1016/j.jbc.2021.101266 |
Ejemplares similares
-
The D614G Mutation Enhances the Lysosomal Trafficking of SARS-CoV-2 Spike
por: Guo, Chenxu, et al.
Publicado: (2020) -
Degron tagging of BleoR and other antibiotic-resistance genes selects for higher expression of linked transgenes and improved exosome engineering
por: Tsai, Shang Jui, et al.
Publicado: (2022) -
Choice of selectable marker affects recombinant protein expression in cells and exosomes
por: Guo, Chenxu, et al.
Publicado: (2021) -
Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants
por: Cacciottolo, Mafalda, et al.
Publicado: (2023) -
Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins
por: Cacciottolo, Mafalda, et al.
Publicado: (2023)